Literature DB >> 1936659

Evaluation of inhibitory guanine nucleotide regulatory protein Gi function in hepatocyte and liver membranes from obese Zucker (fa/fa) rats and their lean (Fa/?) littermates.

P Young1, D M Kirkham, G J Murphy, M A Cawthorne.   

Abstract

Previous studies have shown that hepatocyte and liver membranes from insulin resistant animals exhibit an impairment of inhibitory guanine nucleotide binding regulatory protein, Gi function, such that a Gi defect may contribute towards the diabetic syndrome. In the current studies, it is shown that the demonstration of Gi activity in liver and hepatocyte membranes is dependent critically on the membrane preparation technique. A technique is defined that allows functional Gi activity to be demonstrated in liver and hepatocyte membranes from both lean (Fa/?) and obese (fa/fa) Zucker rats. Consequently, previous reports on the loss of Gi function in insulin resistant states require revaluation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936659     DOI: 10.1007/bf00400274

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  18 in total

1.  P2-purinergic receptors are coupled to two signal transduction systems leading to inhibition of cAMP generation and to production of inositol trisphosphate in rat hepatocytes.

Authors:  F Okajima; Y Tokumitsu; Y Kondo; M Ui
Journal:  J Biol Chem       Date:  1987-10-05       Impact factor: 5.157

2.  Apparent loss of Gi protein activity in the diabetic retina.

Authors:  M Hadjiconstantinou; Z X Qu; S E Moroi-Fetters; N H Neff
Journal:  Eur J Pharmacol       Date:  1988-04-27       Impact factor: 4.432

Review 3.  Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

Authors:  R A DeFronzo
Journal:  Diabetes       Date:  1988-06       Impact factor: 9.461

4.  The glucagon receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it.

Authors:  M D Houslay; J C Metcalfe; G B Warren; T R Hesketh; G A Smith
Journal:  Biochim Biophys Acta       Date:  1976-06-17

5.  Multiple defects occur in the guanine nucleotide regulatory protein system in liver plasma membranes of obese (fa/fa) but not lean (Fa/Fa) Zucker rats: loss of functional Gi and abnormal Gs function.

Authors:  M D Houslay; D J Gawler; G Milligan; A Wilson
Journal:  Cell Signal       Date:  1989       Impact factor: 4.315

6.  Abolition of the expression of inhibitory guanine nucleotide regulatory protein Gi activity in diabetes.

Authors:  D Gawler; G Milligan; A M Spiegel; C G Unson; M D Houslay
Journal:  Nature       Date:  1987 May 21-27       Impact factor: 49.962

7.  Differential effects of tryptophan on glucose synthesis in rats and guinea pigs.

Authors:  S A Smith; K R Elliott; C I Pogson
Journal:  Biochem J       Date:  1978-12-15       Impact factor: 3.857

8.  The regulation of adenylate cyclase in liver membranes of lean and obese mice.

Authors:  N Bégin-Heick; J Welsh
Journal:  Mol Cell Endocrinol       Date:  1988-10       Impact factor: 4.102

9.  Absence of the inhibitory effect of guanine nucleotides on adenylate cyclase activity in white adipocyte membranes of the ob/ob mouse. Effect of the ob gene.

Authors:  N Bégin-Heick
Journal:  J Biol Chem       Date:  1985-05-25       Impact factor: 5.157

10.  The effects of islet activating protein on oral glucose tolerance in the genetically obese fa/fa rat.

Authors:  J Proietto; F Rohner-Jeanrenaud; E Ionescu; B Jeanrenaud
Journal:  Metabolism       Date:  1989-04       Impact factor: 8.694

View more
  2 in total

1.  Demonstration of inhibitory guanine nucleotide regulatory protein (Gi) function in liver and hepatocyte membranes from streptozotocin-treated rats.

Authors:  D M Kirkham; G J Murphy; P Young
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

Review 2.  The functional state of hormone-sensitive adenylyl cyclase signaling system in diabetes mellitus.

Authors:  Alexander O Shpakov; Kira V Derkach
Journal:  J Signal Transduct       Date:  2013-09-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.